High Prevalence of Unrecorded Stage 3 Chronic Kidney Disease in Australia, Brazil, Canada, England, and Spain: The Multinational, Observational REVEAL-CKD Study by Roberto Pecoits-Filho, Kean-Seng Lim, Maria Cristina Ribeiro de Castro, Ana Cebrian, Rafael Santamaria, Naresh Kanumilli, Christian S. Alvarez, Matthew Arnold, Salvatore Barone, Hungta Chen, Krister Järbrink, Navdeep Tangri

Get full text

Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis by Juan Francisco Navarro-González, Alberto Ortiz, Ana Cebrián Cuenca, Lluís Segú, Belén Pimentel, Unai Aranda, Blanca Lopez-Chicheri, Margarita Capel, Elisenda Pomares Mallol, Christian Caudron, Juan José García Sánchez, Roberto Alcázar Arroyo

Get full text

Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project by Juan F. Navarro González, Alberto Ortiz, Ana Cebrián Cuenca, Marta Moreno Barón, Lluís Segú, Belén Pimentel, Unai Aranda, Blanca Lopez-Chicheri, Margarita Capel, Elisenda Pomares Mallol, Christian Caudron, Juan José García Sánchez, Roberto Alcázar Arroyo

Get full text

International Nephrology Masterclass in Chronic Kidney Disease: Rationale, Summary, and Future Perspectives by Francesco Pesce, Maria Vadalà, Edgar Almeida, Beatriz Fernandez, Denis Fouque, Jolanta Malyszko, Kai Schmidt-Ott, Peter Stenvinkel, David C. Wheeler, Samuel Seidu, Ana Cebrian, Nikolay Dimov, Marta Blanco Pardo, Ieva Ziedina, Nayaf Habashi, Joaquin Manrique, Sofia Homem De Melo Marques, Marco Antonio Vaca Gallardo, Larisa Shehaj, Milena Krasimirova Nikolova Vlahova, Luis Mendonça, Sara Ksiazek, Pierangelo Veltri, Giuseppe Pezzi, Gemma Patella, Greta Borelli, Michele Provenzano, Loreto Gesualdo

Get full text